Literature DB >> 29190015

The Microbead Occlusion Model of Ocular Hypertension in Mice.

David J Calkins1,2, Wendi S Lambert3, Cathryn R Formichella3, William M McLaughlin3, Rebecca M Sappington4,5,6.   

Abstract

Glaucoma is a common optic neuropathy that leads to vision loss through the degeneration of retinal ganglion cells (RGCs) and their axons. RGC degeneration in glaucoma is associated with sensitivity to intraocular pressure (IOP) and elevated IOP (also known as ocular hypertension) is the primary modifiable risk factor. Ocular hypertension is the primary characteristic of rodent models for glaucoma research. Intracameral injection of microbeads has evolved as a preferred method of IOP elevation in rodents, particularly in mice. Here, we outline the protocol and method for the Microbead Occlusion Model in mice. We highlight the importance of anesthesia choice and the utilization of glass micropipettes in combination with a micromanipulator and microsyringe pump for the successful execution of the model.

Entities:  

Keywords:  Glaucoma; Intraocular pressure; Microbead; Mouse model; Ocular hypertension; Rodent

Mesh:

Year:  2018        PMID: 29190015     DOI: 10.1007/978-1-4939-7407-8_3

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  19 in total

1.  Elevated ocular pressure reduces voltage-gated sodium channel NaV1.2 protein expression in retinal ganglion cell axons.

Authors:  Michael L Risner; Nolan R McGrady; Silvia Pasini; Wendi S Lambert; David J Calkins
Journal:  Exp Eye Res       Date:  2019-11-14       Impact factor: 3.467

2.  Live, die, or regenerate? New insights from multi-omic analyses.

Authors:  Nicole Y Tsai; Derek S Welsbie; Xin Duan
Journal:  Neuron       Date:  2022-08-17       Impact factor: 18.688

3.  Axon hyperexcitability in the contralateral projection following unilateral optic nerve crush in mice.

Authors:  Nolan R McGrady; Joseph M Holden; Marcio Ribeiro; Andrew M Boal; Michael L Risner; David J Calkins
Journal:  Brain Commun       Date:  2022-10-03

4.  Oral administration of the iron chelator deferiprone protects against loss of retinal ganglion cells in a mouse model of glaucoma.

Authors:  Qi N Cui; Albert R Bargoud; Ahmara G Ross; Ying Song; Joshua L Dunaief
Journal:  Exp Eye Res       Date:  2020-02-08       Impact factor: 3.467

Review 5.  Adaptive responses to neurodegenerative stress in glaucoma.

Authors:  David J Calkins
Journal:  Prog Retin Eye Res       Date:  2021-02-25       Impact factor: 19.704

6.  A Novel Reporter Mouse Uncovers Endogenous Brn3b Expression.

Authors:  Adam M Miltner; Yesica Mercado-Ayon; Simranjeet K Cheema; Pengfei Zhang; Robert J Zawadzki; Anna La Torre
Journal:  Int J Mol Sci       Date:  2019-06-14       Impact factor: 5.923

7.  Early-Stage Ocular Hypertension Alters Retinal Ganglion Cell Synaptic Transmission in the Visual Thalamus.

Authors:  Ashish Bhandari; Jennie C Smith; Yang Zhang; Aaron A Jensen; Lisa Reid; Toni Goeser; Shan Fan; Deepta Ghate; Matthew J Van Hook
Journal:  Front Cell Neurosci       Date:  2019-09-19       Impact factor: 5.505

Review 8.  Organ Cultures for Retinal Diseases.

Authors:  José Hurst; Agnes Fietz; Teresa Tsai; Stephanie C Joachim; Sven Schnichels
Journal:  Front Neurosci       Date:  2020-11-25       Impact factor: 4.677

9.  Longitudinal assessment of optic nerve head changes using optical coherence tomography in a primate microbead model of ocular hypertension.

Authors:  Anita S Y Chan; Tin Aung Tun; John C Allen; Myoe Naing Lynn; Sai Bo Bo Tun; Veluchamy Amutha Barathi; Michaël J A Girard; Tin Aung; Makoto Aihara
Journal:  Sci Rep       Date:  2020-09-07       Impact factor: 4.379

10.  GLP-1 Receptor Agonist NLY01 Reduces Retinal Inflammation and Neuron Death Secondary to Ocular Hypertension.

Authors:  Jacob K Sterling; Modupe O Adetunji; Samyuktha Guttha; Albert R Bargoud; Katherine E Uyhazi; Ahmara G Ross; Joshua L Dunaief; Qi N Cui
Journal:  Cell Rep       Date:  2020-11-03       Impact factor: 9.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.